The myths that drive therapeutic inertia in multiple sclerosis: a cost-effectiveness analysis of high-efficacy drugs in Brazil.

Leonardo Zumerkorn Pipek João Vitor Mahler Rafaela Farias Vidigal Nascimento Jefferson Becker Samira Luisa Dos Apóstolos Pereira Tarso Adoni Guilherme Diogo da Silva Dagoberto Callegaronull null

Published in: Arquivos de neuro-psiquiatria (2024)

Keyphrases